Probi and China National Pharmaceutical Foreign Trade Corporation have signed a License & Supply Agreement
This press release was originally released on 29th March 2021. The correct, full name of China National Pharmaceutical Foreign Trade Corporation and changes to the company description and quotes are hereby updated.
The Swedish probiotic supplier, Probi[®] and China National Pharmaceutical Foreign Trade Corporation (SINOPHARM FORIGN TRADE), a wholly-owned subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM), has entered a partnership to expand the offering of premium probiotic offerings in the Chinese market on Feb 5th, 2021.
SINOPHARM FORIGN TRADE will launch